Lei Yuan

机构：Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine · ORCID：0000-0003-2170-7227

发表论文 30 篇 · 总被引 395 次 · h-index 11

代表论文

• ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer (2025 · Signal Transduction and Targeted Therapy · 被引 30)
• EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis (2025 · Cell Death and Disease · 被引 24)
• BACH1 as a potential target for immunotherapy in glioblastomas (2021 · International Immunopharmacology · 被引 21)
• A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma (2019 · Journal of Thoracic Disease · 被引 21)
• A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma (2021 · Frontiers in Neurology · 被引 17)
• Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies (2022 · Frontiers in Oncology · 被引 15)